Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
---|
03/16/1999 | US5883127 Vision defects, salts |
03/16/1999 | US5883124 Administering phenylacetic acid derivative and retinoid to treat tumors |
03/16/1999 | US5883116 3-(2'-alkoxybenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease |
03/16/1999 | US5883113 Tyrosine kinase inhibitors; antiproliferative and anticarcinogenic agents; diabetes, arthritis, restenosis, atherosclerosis |
03/16/1999 | US5883108 Combination therapy for treating glaucoma |
03/16/1999 | US5882896 M protein |
03/16/1999 | US5882885 Polypeptides and polynucleotides |
03/16/1999 | US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae. |
03/16/1999 | CA2244232A1 Novel def |
03/16/1999 | CA2186513C Benzisothiazoles derivatives as inhibitors of 5-lipoxygenase biosynthesis |
03/16/1999 | CA2073226C Pyrazolopyrimidinone antianginal agents |
03/11/1999 | WO1999011649A2 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same |
03/11/1999 | WO1999011620A1 Branched alkoxy-subsituted 2-aminopyridines as nos inhibitors |
03/11/1999 | WO1999011605A1 Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives |
03/11/1999 | WO1999011275A2 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
03/11/1999 | WO1999011270A1 Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate |
03/11/1999 | WO1999011258A1 Lymphocyte function antigen-1 antagonists |
03/11/1999 | WO1999011244A1 Sustained release drug delivery devices |
03/11/1999 | WO1999011239A1 Method for preparing pharmaceutical formulations |
03/11/1999 | CA2302805A1 Use of immunostimulatory oligonucleotides for preventing or reducing antigen-stimulated, granulocyte-mediated inflammation |
03/11/1999 | CA2301325A1 Method for preparing pharmaceutical formulations |
03/11/1999 | CA2300850A1 Pharmaceutical compositions for the treatment of ocular inflammations comprising dexamethasone palmitate |
03/11/1999 | CA2294074A1 Parp inhibitors, pharmaceutical compositions comprising same, and methods of using same |
03/10/1999 | EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus |
03/10/1999 | EP0900847A2 Phosphoribosyl transferase from Staphylococcus aureus |
03/10/1999 | EP0900846A2 Nucleic acid encoding Streptococcus pneumoniae response regulator |
03/10/1999 | EP0900845A2 Signal recognition particle polypeptides and polynucleotides |
03/10/1999 | EP0900844A2 Membrane protein of Staphylococcus aureus |
03/10/1999 | EP0900843A2 FfH polypeptide from Streptococcus |
03/10/1999 | EP0900799A1 Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones |
03/10/1999 | EP0900219A1 Heterocyclic compounds |
03/10/1999 | EP0900218A1 Heterocyclic compounds |
03/10/1999 | EP0900211A1 Thiadiazolyl(thio)ureas useful as matrix metalloprotease inhibitors |
03/10/1999 | EP0900204A1 Heterocyclic compounds |
03/10/1999 | EP0900202A1 3-alkoxypyridine-2-carboxylic acid amide esters, their preparation and their use as drugs |
03/10/1999 | EP0900201A1 Pyridinyl-2-cyclopenten-1-ones as selective cyclooxygenase-2 inhibitors |
03/10/1999 | EP0900081A1 Inhibitors of farnesyl-protein transferase |
03/10/1999 | EP0900080A1 Novel indole and benzothiazole derivatives |
03/09/1999 | US5880141 Controlling, modulating and inhibiting tyrosine kinase signal transduction |
03/09/1999 | US5880107 Sodium hyaluronate based ophthalmic formulation for use in eye surgery |
03/09/1999 | US5880100 Method for inhibiting binding of human lens cells |
03/09/1999 | CA2243656A1 Response regulator |
03/08/1999 | CA2242476A1 Novel compositions containing cyclosporin |
03/04/1999 | WO1999010308A1 Biphenyl derivatives substituted by an aromatic or heteroaromatic radical and pharmaceutical and cosmetic compositions containing same |
03/04/1999 | WO1999009985A1 Inhibitors of prenyl-protein transferase |
03/04/1999 | WO1999009968A1 Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption |
03/04/1999 | WO1999009955A2 Lipid-containing compositions and uses thereof |
03/04/1999 | WO1998055641A3 Somatic gene therapy to suppress secondary cataract formation |
03/04/1999 | WO1998055606A3 Lactoferrin receptor genes of moraxella |
03/04/1999 | CA2301770A1 Inhibitors of prenyl-protein transferase |
03/04/1999 | CA2301519A1 Ophthalmic compositions for soft contact lens, method of enhancing wettability of soft contact lens, and method of inhibiting terpenoid adsorption |
03/04/1999 | CA2242260A1 Spo0j1 |
03/04/1999 | CA2242258A1 Novel compounds |
03/03/1999 | EP0899338A2 Seryl tRNA synthetase of Streptococcus pneumoniae (serS) |
03/03/1999 | EP0899336A2 Streptococcus pneumoniae spoIIIE protein |
03/03/1999 | EP0899334A2 FtsZ polypeptides from Streptococcus pneumoniae |
03/03/1999 | EP0899333A2 Ribonucleotide reductase gene nrdD from Staphylococcus aureus |
03/03/1999 | EP0899329A2 DextranaseB gene from Streptococcus pneumoniae |
03/03/1999 | EP0745080B1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace |
03/03/1999 | CN1209743A Remedy for keratoconjunctival diseases |
03/03/1999 | CA2242313A1 Signal recognition particle polypeptides and polynucleotides |
03/02/1999 | US5877342 Skin disorders; respiratory system disorders; cardiovascular disorders |
03/02/1999 | US5877211 Prostaglandins |
03/02/1999 | US5877190 Substituted biphenyl compounds |
03/02/1999 | US5877172 Process for isolating galanthamine |
03/02/1999 | US5877154 Administering a polypeptide |
03/02/1999 | US5876709 Ophthalmic composition containing active Vitamin D |
03/02/1999 | CA2242315A1 Mecb |
03/02/1999 | CA2242252A1 Dexb |
03/02/1999 | CA2241417A1 Novel ffh |
03/02/1999 | CA2062001C Stabilized pvp-i solutions |
03/01/1999 | CA2242311A1 Novel compounds |
02/28/1999 | CA2241427A1 Novel pyrr homolog |
02/28/1999 | CA2241400A1 Ftsy |
02/26/1999 | CA2241431A1 Novel spoiiie |
02/25/1999 | WO1999009147A1 Truncated platelet-activating factor acetylhydrolase |
02/25/1999 | WO1999009146A1 Human serum inducible kinase (snk) |
02/25/1999 | WO1999009049A1 Hypoxia-regulated genes |
02/25/1999 | WO1999009046A1 Hypoxia-regulated genes |
02/25/1999 | WO1999009025A2 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1h-indole derivatives interacting with the dopamine d4 receptor |
02/25/1999 | WO1999008682A1 A method of preventing or treating estrogen-dependent diseases and disorders |
02/25/1999 | WO1999008678A1 Heterocyclic vinylethers against neurological disorders |
02/25/1999 | WO1999008636A1 Collagen-base auxiliary agent for ophthalmic surgery |
02/25/1999 | WO1999008521A1 Treatment or prophylaxis of retinal pathology and spinal cord injury |
02/25/1999 | CA2300135A1 Treatment or prophylaxis of retinal pathology and spinal cord injury |
02/25/1999 | CA2269039A1 Collagen-base auxiliary agent for ophthalmic surgery |
02/25/1999 | CA2241403A1 Murb |
02/24/1999 | EP0897303A1 Inhibitors of farnesyl-protein transferase |
02/24/1999 | EP0897301A1 Method of treating otitis media with uridine triphosphates and related compounds |
02/24/1999 | CN1209123A New barbituric acid derivatives, processes for their prodn. and pharmaceutical agent contg. same |
02/24/1999 | CN1209068A Hyaluronic acid as DNA carrier for gene therapy and VEGF antisense DNA to treat abnormal retinal vascularization |
02/24/1999 | CN1209065A Otic microbial combinations |
02/24/1999 | CN1208624A Application of theaflavine for prepn. of medicine for treating deafness |
02/24/1999 | CN1042228C Antiallergic imidazoazepines |
02/23/1999 | US5874460 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents |
02/23/1999 | US5874459 Reducing nausea during chemotherapy; therapy for glaucoma, organ transplants |
02/23/1999 | US5874224 Growth factor receptor binding protein |
02/18/1999 | WO1999007681A1 2-acylaminopropanamines as tachykinin receptor antagonists |
02/18/1999 | CA2298702A1 2-acylaminopropanamines as tachykinin receptor antagonists |
02/17/1999 | EP0897011A2 Novel arginine deiminase |